期刊文献+

如何开展高质量临床研究 被引量:10

How to carry out high quality clinical trial
原文传递
导出
摘要 以高质量的大型临床研究结果为依据的循证医学思维逐渐被广大临床医生接受,因此大型医疗机构的临床医生主导或参与临床研究的积极性空前高涨。然而,如何提高大型临床研究的研究质量和管理水平,使其结果得到国际认可是我们面临的巨大挑战。本文从目前国内多数大型医疗机构面临的困境以及研究模式转变所提供的发展空间切入,提出开展高质量临床研究需要做到密切关注学科领域的发展、培养临床科研的思维.保证科学严谨的设计,规范每个操作环节的实施步骤和细节,以及建立一支分工协作、沟通通畅的团队等方面来提高研究质量。当前我国的诊疗规范和疾病指南里鲜有国人的数据支持,我们应根据实际情况来科学地制定设计研究方案并严谨执行,为制定适合我国疾病特征的诊疗指南提供高级别的证据。 Evidence-based medicine derived from large -scale clinical trials has been widely accepted by clinicians, which strongly motivates the clinicians in medical institutions to eonduct or participate in clinical trials. However, how to improve the clinical trial quality and management to achieve worldwide aceeptanee still remains challenging. By analyzing the difficulties faced by the majority of large Chinese clinical institutions and the opportunities during the evolvement of research modes, this paper proposes to improve the quality of clinical trial by closely following the domain development, raising clinical research thinking, ensuring rigorous research design, standardizing the steps and details of each operational session, as well as establishing a collaborative and well- communicated team. So far there is limited data support in therapeutic standards and guidelines in China. We have systematically designed and r/go^usly operated the research program based on the actual situation, whereby we have derived a set of high-quality disease guidelines that are adapted to the national disease characteristics in China.
作者 徐徕 肖毅
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2017年第7期763-765,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 临床研究 前瞻性随机对照试验 质量管理 Clinical research Randomized controlled trial Quality management
  • 相关文献

参考文献3

二级参考文献22

  • 1GLOBOCAN 2008. Esti mated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. http://globocan.iarc.fr/factsheet.asp.
  • 2Jin M, Lu H, Li J, et al. Randomized 3-armed phase II1 study of S-1 monotherapy versus S-1/CDDP (SP) versus 5-FU/CDDP (FP) in patients (pts) with advanced gastric cancer (AGC): SC-101 study. J Clin Oncol, 2008,26 suppl : abstr 4533.
  • 3Tsuburaya A, Sakamoto J, Morita S, et al. A randomized phase Ⅲ trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial. Jpn J Clin Oncol, 2005,35 : 672-675.
  • 4Katayama H, ho S, Sano T, et al. A Phase Ⅱ study of systemic chemotherapy with (DCS) followed by surgery docetaxel, cisplatin, and S-1 in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. Jpn J Clin Oncol, 2012,42: 556-559.
  • 5Ishigami H, Kitayama J, Kaisaki S, et al. Phase Ⅱ study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol, 2010,21:67-70.
  • 6Lee J, Lim do H, Kim S, et al. Phase Ⅲ trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST triM. J Clin Oncol, 2012,30:268-273.
  • 7Fuchs CS, Tepper JE, Niedzwiecki D, et al. Postoperative adjuvant chemoradiation for gastric or gastroesophageal junction (GEJ) adenocarcinoma using epirubicin, cisplatin, and infusional (CI) 5-FU (ECF) before and after CI 5-FU and radiotherapy (CRT) compared with bolus 5-FU/LV before and after CRT: Intergroup trial CALGB 80101. J Clin Oncol, 2011,29 suppl : abstr 4003.
  • 8Emilio B, Irene F, Maria D, et al. Intergroup Trial of Adjuvant Chemotherapy in Adenocareinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer. J Clin Oncol, 2012,30 suppl: abstr LBA4001.
  • 9Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial) : muhicentre, randomised controlled trial[ J ]. Lancet, 2005, 365 (9472) : 1718-1726.
  • 10Buunen M, Veldkamp R, Hop WC, et al. Survival after laparo- scopic surgery versus open surgery for colon cancer: long-term out- come of a randomised clinical trial[ J]. Lancet Oneol, 2009, 10 ( 1 ) : 44-52. DOI: 10. 1016/S1470-2045(08)70310-3.

共引文献156

同被引文献108

引证文献10

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部